58CC823E-2C19-4331-BC11-92BED99D6381.jpeg

The Big Pharma giant Bayer has just won approval from the US Justice Department for the $62.5 billion dollar takeover of the agrichemical behemoth Monsanto. The deal, which was solidified on Tuesday, has many people on edge knowing that Bayer, a company with a sordid history of corruption is merging with Monsanto, the company who has made an empire with its pesticide, herbicide, and genetically-engineered seed empire.

As DW reports, as part of Bayer’s agreement with US antitrust enforcers, the German firm will be required to divest some $9 billion in assets. Regulators said they directed Bayer to sell off its entire cotton, canola, soybean and vegetable seeds businesses, as well as its digital farming business. It will also sell its Liberty herbicide, which competes directly with Monsanto’s product Roundup.

Prior to this sell-off of assets, government regulators voiced their fears that the merger of these two companies would hamper competition and be a detriment to both farmers and consumers. Although Bayer’s asset sales were the largest divestiture ever required by the United States, some concerns over this monopoly are still alive, and rightfully so.

[READ MORE]

You may also like

There is something wrong with Feed URL